Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories

This publication has 10 references indexed in Scilit:

• Mechanism of failed labor after fetal death and its treatment with prostaglandin E2
  American Journal of Obstetrics and Gynecology, 1979
• VAGINAL PROSTAGLANDIN E₂ IN THE MANAGEMENT OF FETAL INTRAUTERINE DEATH
  BJOG: An International Journal of Obstetrics and Gynaecology, 1978
• The Effects of Intramuscular Injections of 15(S)-15-Methyl Prostaglandin F2α in Failed Abortions**Supported by Grant 73049 from The Rockefeller Foundation and by The Upjohn Company, Kalamazoo, Mich.††Presented at the Ninth World Congress on Fertility and Sterility and the Thirty-Third Annual Meeting of The American Fertility Society, April 12 to 16, 1977, Miami Beach, Fla.
  Fertility and Sterility, 1977
• Induction of labor in patients with missed abortion and fetal death in utero with prostaglandin E2 suppositories
  American Journal of Obstetrics and Gynecology, 1977
• EFFECTS OF INTRAMUSCULAR INJECTIONS OF 15(S)-15-METHYL PROSTAGLANDIN-F2ALPHA IN FAILED ABORTIONS
  1977
• MANAGEMENT OF INTRAUTERINE FETAL DEMISE AND MISSED ABORTION USING PROSTAGLANDIN-E2 VAGINAL SUPPOSITORIES
  1976
• Water intoxication associated with oxytocin administration during saline-induced abortion
  American Journal of Obstetrics and Gynecology, 1975
• THE USE OF PROSTAGLANDIN E₂ IN THE MANAGEMENT OF INTRAUTERINE DEATH, MISSED ABORTION AND HYDATIDIFORM MOLE
  BJOG: An International Journal of Obstetrics and Gynaecology, 1971
• Use of Prostaglandin E2 in the Management of Missed Abortion, Missed Labour, and Hydatidiform Mole
  BMJ, 1970
• Fetal death in utero
  American Journal of Obstetrics and Gynecology, 1957